PLS240
N/A
Report date: 2023/05/05 20:00:40
NME
Base Information
Drug NamePLS240
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPathalys Pharma Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A